Lawsuits Over Opioid-Addicted Infants Will Not Be Consolidated in Separate MDL

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has decided not to establish separate pretrial proceedings for the growing number of lawsuits involving opioid-addicted infants, indicating that there is sufficient overlap with claims brought by states and municipalities pursuing damages stemming from the opioid crisis to consolidate the claims as part of a single multidistrict litigation (MDL).

There are currently more than 1,300 opioid addiction lawsuits filed in the federal court system, each seeking damages from various manufacturers and distributors of the powerful narcotic medications over addiction and abuse problems that have plagued the nation in the recent years.

Given common questions of fact and law raised in the claims, the U.S. JPML established centralized proceedings for the opioid cases last year, consolidating the claims before U.S. District Judge Dan A. Polster in the Northern District of Ohio, for coordinated discovery and pretrial proceedings.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

So far, the litigation has focused primarily on claims for damages stemming from improper marketing and distribution of opiate medications into cities, states and towns nationwide. However, in recent months, a growing number of families have filed individual injury lawsuits on behalf of infants born with neonatal abstinence syndrome (NAS) and other health problems associated with exposure to opioids during pregnancy.

In September, a group of plaintiffs filed a motion seeking to establish a separate MDL for all infant opioid addiction lawsuits, which seek funds for medical monitoring and damages related future treatment that may be required for the rest of the child’s life.

While plaintiffs claimed that insufficient steps are being taken in the original opioid MDL to address the allegations raised in these complaints brought on behalf of infants born dependent on opioids, manufacturers opposed the creation of a separate MDL.

Following oral arguments presented last month, the U.S. JPML issued an order denying transfer (PDF) on Friday, meaning the cases will remain before Judge Polster.

“Few efficiencies will be gained by creating a new MDL for NAS plaintiffs. Discovery regarding the marketing, manufacture, distribution and diversion of prescription opiates in plaintiffs’ cases will substantially overlap with that being undertaken in MDL No. 2804,” the panel determined. “Significantly, the risk of inconsistent pretrial rulings would increase dramatically were we to create another MDL, as plaintiffs request, before a judge in a district outside the Northern District of Ohio.”

The panel noted that the plaintiffs had requested the transferee courts be elsewhere than the Northern District of Ohio, and said it would result in costly duplication of activity and effort, the need for new case management protocols and counsel leadership, and overlapping discovery matters.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns (Posted today)

The FDA has issued a safety communication warning that Zimmer Biomet CPT hip system femoral stems may increase the risk of femur fractures, calling for doctors to avoid its use when possible.

Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference
Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference (Posted yesterday)

The judge presiding over all Change Healthcare lawsuits filed in federal court is holding the first status conference of the litigation, which is expected to grow significantly as Change Healthcare data breach letters continue to be sent to impacted customers.

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted 2 days ago)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.